Muni (Hydrocortisone)

Hydrocortisone penetrates the skin and binds to intracellular glucocorticoid receptors. The resulting complex alters gene expression, suppressing the production of pro‑inflammatory cytokines and chemokines, reducing leukocyte migration, and stabilising cell membranes. This cascade diminishes local inflammation and immune activity.

The dosage of Muni is determined by the prescribing healthcare professional based on the severity of the condition, patient age and the area of skin involved. Typically, a thin layer is applied to the affected area once or twice daily, but exact instructions should follow the prescriber’s order.

Safety data for topical hydrocortisone in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To request Muni, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Muni contains hydrocortisone, a low‑ to medium‑potency corticosteroid, making it suitable for mild to moderate inflammation. Compared with higher‑potency agents such as betamethasone or clobetasol, hydrocortisone carries a lower risk of skin atrophy and systemic effects, but may be less effective for severe plaques, requiring longer treatment periods.

Store Muni at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and excessive heat. Do not freeze. Ensure the container is tightly closed when not in use to maintain product stability.

Muni is applied topically to clean, dry skin. Use a thin, even layer over the affected area and gently rub it in until absorbed. Wash hands before and after application unless the hands are the treatment site. Follow the prescriber’s frequency and duration recommendations.

Serious risks include skin atrophy, telangiectasia, secondary infections (bacterial, fungal, viral), allergic contact dermatitis, and rare systemic adrenal suppression when large areas are treated for prolonged periods. Patients should be monitored for these signs, and therapy should be discontinued if they occur.

Muni should be avoided in individuals with known hypersensitivity to hydrocortisone or any formulation excipients, in skin areas with active viral, fungal or bacterial infections, and on extensive broken skin. Caution is advised for children under two years of age and for patients using other potent corticosteroids without medical supervision.